HemOnc.org offers value

Way back in 2012, I wrote about a wiki Peter Yang and friends created to share clinical knowledge about his field. I was pleased to receive this update from him:

Thank you again for previously supporting our efforts at HemOnc.org to create a collaborative free hematology/oncology reference. We're excited that ASCO's Journal of Oncology Practice just published a manuscript we submitted about the website, which is still going strong and being regularly updated after over 3 years. 

That article notes:

From its inception in November 2011, HemOnc.org has grown rapidly and most recently has detailed information on 383 drugs and 1,298 distinct chemotherapy regimens (not counting variants) in 92 disease subtypes. There are regularly more than 2,000 visitors per week from the United States and international locations. A user evaluation demonstrated that users find the site useful, usable, and recommendable.  

Future enhancements, including more metadata about drugs and increasingly detailed efficacy and toxicity information, will continue to improve the value of the resource.

Congratulations to this team for a job well done and for their contributions to so many people around the world!